Register entry
STRONGBRIDGE DUBLIN LTD
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 5
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
5| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9918984 | RECORLEVlevoketoconazole | use | May 2028 |
| 11020393 | RECORLEVlevoketoconazole | use | Mar 2040 |
| 11278547 | RECORLEVlevoketoconazole | use | Mar 2040 |
| 11903940 | RECORLEVlevoketoconazole | use | Mar 2040 |
| 12377096 | RECORLEVlevoketoconazole | use | Mar 2040 |
| Product | Exclusivity | Until |
|---|---|---|
| RECORLEVLEVOKETOCONAZOLE | ODE-385 Orphan drug | Dec 2028 |
Enquiry
Common questions
- Is STRONGBRIDGE DUBLIN LTD FDA approved?
- STRONGBRIDGE DUBLIN LTD holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.